<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=5574&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="485991" class="table-">
                
                <td>Jan. 26, 2024, 8 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;interferon or glatiramer acetate;mRNA COVID-19 vaccine&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;interferon or glatiramer acetate;mRNA COVID-19 vaccine&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="116236" class="table-">
                
                <td>May 9, 2021, 12:31 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;interferon or glatiramer acetate;mRNA COVID-19 vaccine&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;mRNA COVID-19 vaccine;Ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Biological;Drug&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;vaccine at least two weeks prior to start of ofatumumab (20 mg subcutaneous)&quot;, &quot;treatment_id&quot;: 2294, &quot;treatment_name&quot;: &quot;Bnt162b2+ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+monoclonal antibodies&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least two weeks prior to start of ofatumumab (20 mg subcutaneous)&quot;, &quot;treatment_id&quot;: 2293, &quot;treatment_name&quot;: &quot;Mrna-1273+ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+monoclonal antibodies&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks prior to start of ofatumumab (20 mg subcutaneous)&quot;, &quot;treatment_id&quot;: 2294, &quot;treatment_name&quot;: &quot;Bnt162b2+ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+monoclonal antibodies&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks prior to start of ofatumumab (20 mg subcutaneous)&quot;, &quot;treatment_id&quot;: 2293, &quot;treatment_name&quot;: &quot;Mrna-1273+ofatumumab&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+monoclonal antibodies&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks after start of prescribed interferon&quot;, &quot;treatment_id&quot;: 2215, &quot;treatment_name&quot;: &quot;Bnt162b2+interferon&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+interferons&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks after start of prescribed interferon&quot;, &quot;treatment_id&quot;: 2216, &quot;treatment_name&quot;: &quot;Interferon+mrna-1273&quot;, &quot;treatment_type&quot;: &quot;Interferons+rna based vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment+vaccine&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks after start of prescribed  glatiramer acetate&quot;, &quot;treatment_id&quot;: 2296, &quot;treatment_name&quot;: &quot;Bnt162b2+glatiramer&quot;, &quot;treatment_type&quot;: &quot;Rna based vaccine+other targeted therapies&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine+pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;vaccine at least 4 weeks after start of prescribed glatiramer acetate&quot;, &quot;treatment_id&quot;: 2297, &quot;treatment_name&quot;: &quot;Glatiramer+mrna-1273&quot;, &quot;treatment_type&quot;: &quot;Other targeted therapies+rna based vaccine&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment+vaccine&quot;}]
        </p>
        
    
                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
Jan. 26, 2024, 8 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "interferon or glatiramer acetate;mRNA COVID-19 vaccine", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "interferon or glatiramer acetate;mRNA COVID-19 vaccine", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}]
May 9, 2021, 12:31 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "interferon or glatiramer acetate;mRNA COVID-19 vaccine", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "mRNA COVID-19 vaccine;Ofatumumab", "treatment_type": "Biological;Drug", "pharmacological_treatment": "Pharmacological treatment"}]	[{"arm_notes": "vaccine at least two weeks prior to start of ofatumumab (20 mg subcutaneous)", "treatment_id": 2294, "treatment_name": "Bnt162b2+ofatumumab", "treatment_type": "Rna based vaccine+monoclonal antibodies", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least two weeks prior to start of ofatumumab (20 mg subcutaneous)", "treatment_id": 2293, "treatment_name": "Mrna-1273+ofatumumab", "treatment_type": "Rna based vaccine+monoclonal antibodies", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least 4 weeks prior to start of ofatumumab (20 mg subcutaneous)", "treatment_id": 2294, "treatment_name": "Bnt162b2+ofatumumab", "treatment_type": "Rna based vaccine+monoclonal antibodies", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least 4 weeks prior to start of ofatumumab (20 mg subcutaneous)", "treatment_id": 2293, "treatment_name": "Mrna-1273+ofatumumab", "treatment_type": "Rna based vaccine+monoclonal antibodies", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least 4 weeks after start of prescribed interferon", "treatment_id": 2215, "treatment_name": "Bnt162b2+interferon", "treatment_type": "Rna based vaccine+interferons", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least 4 weeks after start of prescribed interferon", "treatment_id": 2216, "treatment_name": "Interferon+mrna-1273", "treatment_type": "Interferons+rna based vaccine", "pharmacological_treatment": "Pharmacological treatment+vaccine"}, {"arm_notes": "vaccine at least 4 weeks after start of prescribed glatiramer acetate", "treatment_id": 2296, "treatment_name": "Bnt162b2+glatiramer", "treatment_type": "Rna based vaccine+other targeted therapies", "pharmacological_treatment": "Vaccine+pharmacological treatment"}, {"arm_notes": "vaccine at least 4 weeks after start of prescribed glatiramer acetate", "treatment_id": 2297, "treatment_name": "Glatiramer+mrna-1273", "treatment_type": "Other targeted therapies+rna based vaccine", "pharmacological_treatment": "Pharmacological treatment+vaccine"}]